Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/history.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study documentation.SummaryDifference0.0%

- Check33 days agoChange DetectedThe study page now displays a recruitment-closed notice and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users.SummaryDifference0.1%

- Check40 days agoChange DetectedThe revision line at the bottom shows Revision: v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check47 days agoChange DetectedThe Ukraine location entry was updated to standardize the location as Kharkiv Oblast, Ukraine. The city line now reads Kharkiv, Kharkiv Oblast, Ukraine, 61039.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page no longer displays the AbbVie sponsor attribution and the auxiliary sections 'Related Info' and 'Helpful Links Provided by', altering how users access sponsor details and related resources for this study.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.